Profil bibliographique

Véronique Lorgis

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

69Publications signalées

1937Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Breast Cancer Treatment StudiesCancer Treatment and PharmacologyAdvanced Breast Cancer TherapiesGlioma Diagnosis and TreatmentHER2/EGFR in Cancer Research

Publications récentes

Accès ouvert 2026 articleOpenAlex

Updated Results from AVENANCE: Real-World Effectiveness of Avelumab First-Line Maintenance (1LM) in Patients with Advanced Urothelial Carcinoma (aUC) and Analysis of Second-Line Treatment

Harshveer Singh Malhi, Philippe Barthélémy, Yohann Loriot, Constance Thibault et autres

0 citationsIndian Journal of Medical and Paediatric Oncology

2025 articleOpenAlex

1331P TPFm (GORTEC 2019-01): Randomized, non-comparative phase II evaluating induction chemotherapy with cisplatin (P), 5-fluorouracil (F) and docetaxel (T) at standard (TPF) or adapted doses (mTPF) in patients (pts) with locally advanced squamous cell cancer of the head and neck (LA-SCCHN)

Jacques Fayette, Léa Loriguet, Paul Riviere, Amandine Bruyas et autres

0 citationsAnnals of Oncology

Accès ouvert 2025 articleOpenAlex

Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study

Judith Passildas, M Paillard, L. Uwer, Ioana Molnar et autres

1 citationCancer Epidemiology

2025 conference-abstractOpenAlex

AVENANCE real-world study of avelumab first-line (1L) maintenance treatment for advanced urothelial carcinoma (UC): Analyses in low tumor burden subgroups.

Philippe Barthélémy, Yohann Loriot, Constance Thibault, Aude Fléchon et autres

2 citationsJournal of Clinical Oncology

Accès ouvert 2024 articleOpenAlex

Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment

Philippe Barthélémy, Constance Thibault, Aude Fléchon, M. Gross-Goupil et autres

36 citationsEuropean Urology Oncology

Accès ouvert 2024 articleOpenAlex

First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)

Jean-Louis Legoux, Roger Faroux, Nicolas M. Barrière, Karine Le Malicot et autres

2 citationsCancers

Accès ouvert 2024 conference-abstractOpenAlex

Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.

Philippe Barthélémy, Yohann Loriot, Constance Thibault, M. Gross-Goupil et autres

21 citationsJournal of Clinical Oncology

Accès ouvert 2023 articleOpenAlex

2379P AVENANCE: Subgroup analysis of patients (pts) with advanced urothelial carcinoma (aUC) with histological variants from a real-world (RW) study of avelumab first-line maintenance (1LM)

Philippe Barthélémy, Yohann Loriot, Aude Fléchon, M. Gross Goupil et autres

4 citationsAnnals of Oncology

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figure 1 from Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Olivier Humbert, Jean‐Marc Riedinger, Céline Charon‐Barra, Alina Berriolo-Riedinger et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figure 1 from Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Olivier Humbert, Jean‐Marc Riedinger, Céline Charon‐Barra, Alina Berriolo-Riedinger et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Olivier Humbert, Jean‐Marc Riedinger, Céline Charon‐Barra, Alina Berriolo-Riedinger et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Olivier Humbert, Jean‐Marc Riedinger, Céline Charon‐Barra, Alina Berriolo-Riedinger et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.